ArticleInvestigative ophthalmology & visual science2025
Activation of Sigma 1 Receptor Preserves Visual Function After Optic Nerve Injury.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A neuroprotective target in the shadows: a scoping review of pharmacological gaps in σ1R agonists for glutamate-induced neurotoxicity.Frontiers in pharmacology · 2026Pooled it
- Sigma1 Receptor Activation Confers Durable Neuroprotection Following Neonatal Ischemic Retinal Injury.Research square · 2026Article
- Nrf2/HO-1 signaling in retinal neurodegenerative diseases: redox homeostasis, cytoprotection, and therapeutic perspectives.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Purpose: Previous research has indicated that sigma 1 receptor (Sig1R) activation can help retinal ganglion cells (RGCs) survive optic nerve injury. However, in these studies, the treatments were given before the injury. We explored whether activating Sig1R as a post-injury treatment can still preserve visual function. Methods: Wild-type or Sig1R knockout mice were subjected to optic nerve crush (ONC) injury. The contralateral eye served as sham control. Starting 6 hours after ONC, (+)-pentazocine, or (+)-PTZ, was administered daily. Visual acuity, contrast sensitivity, pattern electroretinography (PERG), visual evoked potential (VEP), and imaging of retinal structure and vasculature were evaluated using OptoMotry, ERG, spectral-domain optical coherence tomography, and fluorescein angiography, respectively. Retinal neurons and RGC survival were assessed in retinal whole mounts, and retinal glial activation was detected through glial fibrillary acid protein (GFAP) immunolabeling on retinal cryosections. Oxidative stress levels were measured with dihydroethidium (DHE) staining. Additionally, quantitative reverse transcription PCR was conducted to analyze changes in mRNA expression related to antioxidant (Nrf2, HO-1, NQO1) and inflammatory (IL1β, TNFα, iNOS) pathways. Results: Our results indicate that activating Sig1R with (+)-PTZ after ONC injury effectively preserves visual function. This was demonstrated by enhanced visual acuity, contrast sensitivity, PERG, and VEP responses, as well as improved retinal thickness and vasculature in ONC+PTZ mice. Additionally, activation of Sig1R limits ONC-induced neurodegeneration and glial activation caused by ONC by a mechanism involving increasing antioxidant genes expression (Nrf2, HO-1, NQO1) and decreasing retinal inflammation (IL1β, TNFα, iNOS). Conclusions: These findings suggest that activating Sig1R could be a promising therapeutic approach for preserving visual function even after optic nerve damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.